166 related articles for article (PubMed ID: 3114907)
1. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
[TBL] [Abstract][Full Text] [Related]
2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx J; Bouillon R; Collen D; Geboers J
Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
[TBL] [Abstract][Full Text] [Related]
4. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
Kluft C; Jie AF; Rijken DC; Verheijen JH
Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
[TBL] [Abstract][Full Text] [Related]
5. Diurnal variation of the fibrinolytic system.
Grimaudo V; Hauert J; Bachmann F; Kruithof EK
Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
7. Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor.
Hashimoto Y; Kobayashi A; Yamazaki N; Takada Y; Takada A
Thromb Res; 1988 Aug; 51(3):303-11. PubMed ID: 3140409
[TBL] [Abstract][Full Text] [Related]
8. Increased concentration of the fast-acting plasminogen activator inhibitor in plasma associated with familial venous thrombosis.
Jørgensen M; Bonnevie-Nielsen V
Br J Haematol; 1987 Feb; 65(2):175-80. PubMed ID: 3103670
[TBL] [Abstract][Full Text] [Related]
9. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
Páramo JA; Alfaro MJ; Rocha E
Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
[TBL] [Abstract][Full Text] [Related]
10. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
Lucore CL; Fujii S; Sobel BE
Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.
Hamsten A; Wiman B; de Faire U; Blombäck M
N Engl J Med; 1985 Dec; 313(25):1557-63. PubMed ID: 3934538
[TBL] [Abstract][Full Text] [Related]
12. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
Haire WD; Goldsmith JC; Rasmussen J
Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
[TBL] [Abstract][Full Text] [Related]
13. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
Takada Y; Takada A
Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic activity and species of plasminogen activator in human tears.
Hayashi K; Sueishi K
Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
[TBL] [Abstract][Full Text] [Related]
16. Impaired fibrinolysis in coronary artery disease.
Francis RB; Kawanishi D; Baruch T; Mahrer P; Rahimtoola S; Feinstein DI
Am Heart J; 1988 Apr; 115(4):776-80. PubMed ID: 3128096
[TBL] [Abstract][Full Text] [Related]
17. Increased plasminogen activator inhibition levels in malignancy.
de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator and plasminogen activator inhibitor activities in a reference population.
Krishnamurti C; Tang DB; Barr CF; Alving BM
Am J Clin Pathol; 1988 Jun; 89(6):747-52. PubMed ID: 3259399
[TBL] [Abstract][Full Text] [Related]
20. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
